| 2023-09-12 | -28.7% | news | The Motley Fool | Why Shares of Orthofix Medical Are Plummeting on Tuesday - The Motley Fool |
| 2022-10-11 | -21.1% | legal | SEC EDGAR | OFIX 8-K: 2.02 and (SEC Filing) |
| 2022-10-11 | -21.1% | legal | SEC EDGAR | OFIX 8-K: 1.01, 5.03, 8.01 (SEC Filing) |
| 2022-10-11 | -21.1% | M&A | Business Wire | Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company - Business Wire |
| 2025-08-05 | +15.3% | earnings | Seeking Alpha | Orthofix Medical Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-08-05 | +15.3% | analyst | Seeking Alpha | Orthofix anticipates full-year net sales of $808M–$816M while accelerating U.S. spine distributor transition |
| 2025-08-05 | +15.3% | earnings | Seeking Alpha | Orthofix Medical Inc. (OFIX) Q2 2025 Earnings Call Transcript |
| 2025-08-05 | +15.3% | earnings | Seeking Alpha | Orthofix Medical Inc. GAAP EPS of -$0.36 beats by $0.13, revenue of $203.1M beats by $5.99M |
| 2025-08-05 | +15.3% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-08-06 | +13.6% | earnings | Seeking Alpha | Orthofix Medical Inc. (OFIX) Q2 2024 Earnings Call Transcript |
| 2024-08-06 | +13.6% | earnings | Seeking Alpha | Orthofix reports mixed Q2 results; raises FY24 outlook |
| 2024-08-06 | +13.6% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-01-05 | -12.5% | legal | SEC EDGAR | OFIX 8-K: 1.02, 2.01, 2.03, 5.02, 8.01 (SEC Filing) |
| 2023-11-08 | -11.8% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-08 | -11.8% | legal | SEC EDGAR | OFIX 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2022-11-30 | +11.3% | legal | SEC EDGAR | OFIX 8-K: 8.01 (SEC Filing) |
| 2023-08-08 | +11.0% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-05-06 | -10.8% | earnings | Seeking Alpha | Orthofix Medical Inc. 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-06 | -10.8% | earnings | Seeking Alpha | Orthofix targets $808M to $816M revenue in 2025 with key product launches |
| 2025-05-06 | -10.8% | earnings | Seeking Alpha | Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Call Transcript |
| 2025-05-06 | -10.8% | earnings | Seeking Alpha | Orthofix Medical Inc. GAAP EPS of -$1.35 misses by $0.75, revenue of $193.6M beats by $2.5M |
| 2025-05-06 | -10.8% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-05-07 | +10.6% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-11-08 | +9.4% | news | Seeking Alpha | Orthofix raised to buy by Stifel, new management cited |
| 2024-11-08 | +9.4% | legal | SEC EDGAR | OFIX 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2021-08-06 | +8.8% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-03-05 | +8.6% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-23 | -7.8% | earnings | Seeking Alpha | Orthofix Medical Inc. Q4 2025 Earnings Preview |
| 2023-10-05 | -7.5% | legal | SEC EDGAR | OFIX 8-K: 5.02 (SEC Filing) |
| 2023-01-09 | -7.3% | legal | SEC EDGAR | OFIX 8-K: 2.02 and (SEC Filing) |
| 2022-05-06 | -6.7% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-11-05 | -6.4% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-08-05 | -6.4% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-01-09 | +6.3% | legal | SEC EDGAR | OFIX 8-K: 2.02, 5.02 (SEC Filing) |
| 2024-01-09 | +6.3% | news | Stock Titan | Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results - Stock Titan |
| 2023-03-06 | -6.3% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-04 | -5.9% | earnings | Seeking Alpha | Orthofix outlines $2B VIRATA market launch and narrows 2025 guidance as 7D, Orthopedics drive growth |
| 2025-11-04 | -5.9% | earnings | Seeking Alpha | Orthofix Medical Inc. (OFIX) Q3 2025 Earnings Call Transcript |
| 2025-11-04 | -5.9% | earnings | Seeking Alpha | Orthofix Medical Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-04 | -5.9% | earnings | Seeking Alpha | Orthofix Medical reports mixed Q3 results; narrows FY outlook |
| 2025-11-04 | -5.9% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-04 | -5.9% | earnings | Yahoo Finance | Orthofix Medical Inc (OFIX) Q3 2025 Earnings Call Highlights: Strong Growth in US Spine and ... - Yahoo Finance |
| 2026-02-24 | -5.6% | news | Seeking Alpha | Orthofix extends timeline for 6.5%-7.5% sales CAGR through 2028 as channel optimization matures |
| 2026-02-24 | -5.6% | earnings | Seeking Alpha | Orthofix Medical Inc. (OFIX) Q4 2025 Earnings Call Transcript |
| 2026-02-24 | -5.6% | earnings | Seeking Alpha | Orthofix Medical Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-24 | -5.6% | earnings | Seeking Alpha | Orthofix Medical beats top-line and bottom-line estimates; introduces FY26 outlook |
| 2026-02-24 | -5.6% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-24 | -5.6% | earnings | Quiver Quantitative | ORTHOFIX MEDICAL ($OFIX) Releases Q4 2025 Earnings - Quiver Quantitative |
| 2023-12-15 | +5.6% | legal | SEC EDGAR | OFIX 8-K: 1.01, 5.02, 8.01 (SEC Filing) |
| 2021-06-21 | -5.5% | legal | SEC EDGAR | OFIX 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-02-26 | +4.8% | earnings | Simply Wall St. | How The Orthofix Medical (OFIX) Narrative Is Shifting With Margin Delays And New 2026 Guidance |
| 2024-02-12 | -4.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-02-21 | -4.6% | earnings | TradingView | Orthofix Medical Inc. Revenue Breakdown – NASDAQ:OFIX - TradingView |
| 2025-02-25 | -4.5% | earnings | Seeking Alpha | Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript |
| 2025-02-25 | -4.5% | earnings | Seeking Alpha | Orthofix Medical Inc. 2024 Q4 - Results - Earnings Call Presentation |
| 2025-02-25 | -4.5% | earnings | Seeking Alpha | Orthofix Medical Inc. GAAP EPS of -$0.75 misses by $0.52, revenue of $215.7M beats by $2.98M |
| 2025-02-25 | -4.5% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-06-17 | -4.4% | news | Kalkine Media | Orthofix Medical (NASDAQ:OFIX) Stock Decline Amid Nasdaq Composite Weakness - Kalkine Media |
| 2026-04-21 | -4.4% | news | Business Wire | Orthofix to Report First Quarter 2026 Financial Results |
| 2026-04-21 | -4.4% | earnings | Stock Titan | Orthofix investors get Q1 results May 5, with call at 8:30 a.m. ET - Stock Titan |
| 2026-01-22 | -4.3% | executive | Investing.com | Andrews Julie, CFO of Orthofix, sells $70k in OFIX stock - Investing.com |
| 2024-11-07 | +4.3% | earnings | Seeking Alpha | Orthofix GAAP EPS of -$0.71 misses by $0.37, revenue of $196.6M in-line |
| 2024-11-07 | +4.3% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-01-10 | +3.9% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-20 | -3.9% | news | Investing.com | Orthofix CLO Jorge Cedron sells $47,985 in company stock - Investing.com |
| 2026-04-20 | -3.9% | news | Stock Titan | Orthofix Medical (OFIX) CLO sells shares for RSU tax obligations - Stock Titan |
| 2025-03-12 | -3.9% | legal | SEC EDGAR | OFIX 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-07-06 | -3.7% | legal | SEC EDGAR | OFIX 8-K: 5.02 (SEC Filing) |
| 2022-12-05 | +3.7% | legal | SEC EDGAR | OFIX 8-K: 8.01 (SEC Filing) |
| 2025-09-09 | -3.6% | news | Seeking Alpha | Orthofix Medical: Spending, Not Producing Additional Income |
| 2025-09-09 | -3.6% | news | Seeking Alpha | Orthofix Medical: Spending, Not Producing Additional Income (NASDAQ:OFIX) - Seeking Alpha |
| 2024-04-12 | -3.5% | legal | SEC EDGAR | OFIX 8-K: 5.02 (SEC Filing) |
| 2023-06-21 | -3.3% | legal | SEC EDGAR | OFIX 8-K: 5.02 and (SEC Filing) |
| 2026-01-16 | -3.2% | legal | DirectorsTalk Interviews | Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 58% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews |
| 2026-01-16 | -3.2% | news | simplywall.st | This Insider Has Just Sold Shares In Orthofix Medical - simplywall.st |
| 2024-11-10 | +3.0% | earnings | Seeking Alpha | Orthofix Medical Inc. (OFIX) Q3 2024 Earnings Call Transcript |
| 2026-02-25 | +3.0% | news | Motley Fool | Boyd Group Stock Up 20% Since $141 IPO as $9 Million Fund Bet Signals Conviction |
| 2026-02-25 | +3.0% | news | Motley Fool | What's Behind a New $6.5 Million Bet on Middleby With Stock Down 5% in One Year? |
| 2026-02-25 | +3.0% | news | Motley Fool | Brookdale Stock Up 200%, but One Fund Dumped Its $6.5 Million Stake Last Quarter |
| 2022-08-08 | -3.0% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Orthofix Medical (OFIX) - Zacks Investment Research |
| 2024-01-17 | -2.9% | legal | SEC EDGAR | OFIX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-02 | -2.9% | earnings | Insider Monkey | Orthofix Medical Inc. (OFIX) Target Reduced at Canaccord Following Q4 Results and 2026 Outlook Update |
| 2026-03-02 | -2.9% | earnings | Yahoo Finance | Orthofix Medical Inc. (OFIX) Target Reduced at Canaccord Following Q4 Results and 2026 Outlook Update - Yahoo Finance |
| 2022-11-03 | -2.6% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-09-23 | -2.5% | legal | SEC EDGAR | OFIX 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-04-07 | -2.5% | legal | SEC EDGAR | OFIX 8-K: 1.01 and 1.02 (SEC Filing) |
| 2023-12-01 | -2.4% | legal | SEC EDGAR | OFIX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-06 | +2.3% | news | AD HOC NEWS | The Truth About Orthofix Medical Inc (OFIX): Underdog Stock or Total Flop? - AD HOC NEWS |
| 2025-09-18 | -2.2% | legal | Claim Depot | Orthofix Medical Inc. Securities Lawsuit Investigation - Claim Depot |
| 2023-10-03 | -2.2% | legal | SEC EDGAR | OFIX 8-K: 5.02 (SEC Filing) |
| 2022-11-21 | -2.2% | legal | SEC EDGAR | OFIX 8-K: 8.01 and (SEC Filing) |
| 2026-01-15 | -2.1% | news | simplywall.st | Further weakness as Orthofix Medical (NASDAQ:OFIX) drops 9.0% this week, taking five-year losses to 68% - simplywall.st |
| 2022-02-25 | +2.1% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-27 | -2.0% | news | Stock Titan | Vanguard realignment lists 0% stake in Orthofix (OFIX) after reporting change - Stock Titan |
| 2023-01-04 | -1.7% | M&A | Business Wire | Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company - Business Wire |
| 2026-03-16 | +1.5% | news | Zacks | Down 12.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Orthofix (OFIX) |
| 2025-11-11 | +1.5% | news | Seeking Alpha | Orthofix Medical Inc. (OFIX) Presents at UBS Global Healthcare Conference 2025 Transcript |
| 2025-02-24 | -1.5% | earnings | Seeking Alpha | Orthofix Medical Inc. Q4 2024 Earnings Preview |
| 2022-04-08 | -1.3% | legal | SEC EDGAR | OFIX 8-K: 5.02 (SEC Filing) |
| 2024-08-26 | +1.3% | legal | Newswire.com | NASDAQ:OFIX Lawsuit NOTICE: Investors Who Lost Money With Shares of Orthofix Medical Inc. (NASDAQ:OFIX) Should Contact the Shareholders Foundation - Newswire.com |
| 2024-04-22 | -1.2% | legal | SEC EDGAR | OFIX 8-K: 1.01 and (SEC Filing) |
| 2022-12-27 | +1.2% | legal | SEC EDGAR | OFIX 8-K: 8.01 (SEC Filing) |
| 2021-12-14 | +1.2% | legal | SEC EDGAR | OFIX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-11 | -1.1% | legal | Business Wire | OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical Inc. – OFIX - Business Wire |
| 2025-03-19 | +1.0% | legal | Seeking Alpha | Orthofix gets FDA clearance and CE Mark for its limb preservation solution |
| 2021-04-30 | +1.0% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-06-20 | +1.0% | legal | SEC EDGAR | OFIX 8-K: 5.02, 5.03, 5.07, 7.01, 8.01 (SEC Filing) |
| 2026-04-09 | +1.0% | news | Business Wire | Orthofix Realigns Spine Leadership to Strengthen Focus and Execution |
| 2026-04-09 | +1.0% | legal | SEC EDGAR | OFIX 8-K: 2.02, 5.02 (SEC Filing) |
| 2026-04-09 | +1.0% | earnings | Stock Titan | Orthofix cuts a spine leadership layer as Q1 sales hit $196.7M - Stock Titan |
| 2026-04-09 | +1.0% | analyst | Investing.com | Canaccord reiterates Orthofix Medical stock rating on leadership changes - Investing.com |
| 2026-04-09 | +1.0% | earnings | Stock Titan | Orthofix (NASDAQ: OFIX) posts Q1 prelim sales, realigns spine leadership - Stock Titan |
| 2026-04-10 | +0.9% | legal | Stock Titan | OFIX SEC Filings - Orthofix Med Inc 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2023-05-09 | +0.9% | legal | SEC EDGAR | OFIX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-08-07 | -0.9% | news | Seeking Alpha | Orthofix Medical: Compelling Valuation Supported By Insider Purchases |
| 2025-09-15 | -0.9% | news | Insider Monkey | Do You Believe in the Growth Potential of Orthofix Medical (OFIX)? - Insider Monkey |
| 2024-06-20 | -0.8% | legal | SEC EDGAR | OFIX 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-11-07 | +0.7% | analyst | simplywall.st | Here's What Analysts Are Forecasting For Orthofix Medical Inc. (NASDAQ:OFIX) After Its Third-Quarter Results - simplywall.st |
| 2024-09-26 | -0.7% | news | GlobeNewswire | ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orthofix Medical - GlobeNewswire |
| 2023-09-14 | -0.6% | legal | SEC EDGAR | OFIX 8-K: 5.02, 7.01, 8.01 (SEC Filing) |
| 2022-06-07 | -0.5% | legal | SEC EDGAR | OFIX 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-03-15 | +0.4% | news | AD HOC NEWS | Orthofix Medical Inc Stock (ISIN: US6875231068) Faces Margin Pressure as Spine Segment Growth Slows - AD HOC NEWS |
| 2026-03-14 | +0.4% | earnings | Simply Wall St. | Orthofix Medical (OFIX) Narrative Shifts As Analysts Recut Targets And Profitability Timelines |
| 2023-04-07 | -0.3% | legal | SEC EDGAR | OFIX 8-K: 5.02 and (SEC Filing) |
| 2026-04-19 | -0.3% | earnings | MarketBeat | Orthofix Medical Inc. (NASDAQ:OFIX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat |
| 2026-04-19 | -0.3% | news | UBND thành phố Hải Phòng | Is Orthofix (OFIX) stock attracting cautious sentiment (Smart Money Active) 2026-04-18 - Trending Stock Ideas - UBND thành phố Hải Phòng |
| 2026-04-18 | -0.3% | legal | PR Newswire | Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX - PR Newswire |
| 2026-04-18 | -0.3% | news | Cổng thông tin điện tử tỉnh Lào Cai | Orthofix (OFIX) Stock: Institutional Signals (Buying Pressure) 2026-04-18 - Wall Street Picks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-03-19 | +0.2% | news | Stock Titan | Orthofix (OFIX) executive logs tax-related sale, retains over 160K shares - Stock Titan |
| 2025-09-01 | +0.1% | news | Investing.com | Orthofix Medical’s SWOT analysis: spine firm’s stock faces growth hurdles - Investing.com |
| 2026-04-25 | — | earnings | Simply Wall St. | How The Orthofix Medical (OFIX) Story Is Shifting After Q4 Models And 2026 Guidance |